Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

ABBOTT LABORATORIES : Goldman Sachs gives a Sell rating

share with twitter share with LinkedIn share with facebook
08/27/2020 | 03:16pm EDT

Goldman Sachs analyst reiterate his Sell rating on the stock. The target price remains unchanged at USD 94.

© MarketScreener with dpa-AFX Analyser 2020

Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES 3.35% 109.48 Delayed Quote.26.04%
THE GOLDMAN SACHS GROUP, INC. 1.23% 205.4 Delayed Quote.-10.67%
share with twitter share with LinkedIn share with facebook
All news about ABBOTT LABORATORIES
10/22Quest raises profit forecast as COVID-19 tests demand to jump
RE
10/22ABBOTT LABORATORIES : Reports third-quarter 2020 results, achieves strong double..
AQ
10/21ABBOTT LABORATORIES : Raises 2020 Earnings Guidance
DJ
10/21ABBOTT LABORATORIES : 3Q Profit, Sales Rise on Covid-19 Testing
DJ
10/21Abbott says COVID-19 test demand to grow in 2021
RE
10/21ABBOTT : 3Q Earnings Snapshot
AQ
10/21ABBOTT LABORATORIES : Results of Operations and Financial Condition, Financial S..
AQ
10/21Abbott quarterly profit rises 28.3% on strong sales of COVID-19 tests
RE
10/21ABBOTT : Reports Third-Quarter 2020 Results; Achieves Strong Double-Digit Earnin..
PR
10/20ABBOTT LABORATORIES : - improved mental and physical condition is directly linke..
AQ
More news
Financials (USD)
Sales 2020 33 891 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 202 M - -
P/E ratio 2020 44,7x
Yield 2020 1,32%
Capitalization 194 B 194 B -
EV / Sales 2020 6,05x
EV / Sales 2021 5,27x
Nbr of Employees 107 000
Free-Float 88,8%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 117,78 $
Last Close Price 109,48 $
Spread / Highest target 18,7%
Spread / Average Target 7,58%
Spread / Lowest Target -25,1%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES26.04%193 838
MEDTRONIC PLC-1.42%146 850
BECTON, DICKINSON AND COMPANY-11.35%68 525
HOYA CORPORATION15.74%43 777
BAXTER INTERNATIONAL INC.-2.60%41 379
DEXCOM, INC.80.94%37 133